Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Profit After Tax

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Profit After Tax History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit After Tax ₹707 Cr₹528 Cr₹562 Cr₹703 Cr₹419 Cr

What is the latest Profit After Tax of EMCURE PHARMACEUTICALS ?

The latest Profit After Tax ratio of EMCURE PHARMACEUTICALS is ₹707 Cr based on Mar2025 Consolidated results.
Year Profit After Tax
Mar2025₹707 Cr
Mar2024₹528 Cr
Mar2023₹562 Cr
Mar2022₹703 Cr
Mar2021₹419 Cr

How is Profit After Tax of EMCURE PHARMACEUTICALS Trending?

Years Profit After Tax % Change
Mar2025 ₹707 Cr
34.10
Mar2024 ₹528 Cr
-6.10
Mar2023 ₹562 Cr
-20.03
Mar2022 ₹703 Cr
67.84
Mar2021 ₹419 Cr -

Compare Profit After Tax of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹30,219.4 Cr 8.4% 11.1% 53.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

8.4%

11.1%

53.8%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses